| Targeting adaptive glioblastoma: an overview of proliferation and invasion Q Xie, S Mittal, ME Berens Neuro-oncology 16 (12), 1575-1584, 2014 | 275 | 2014 |
| Proliferation and invasion: plasticity in tumor cells CF Gao, Q Xie, YL Su, J Koeman, SK Khoo, M Gustafson, BS Knudsen, ... Proceedings of the National Academy of Sciences 102 (30), 10528-10533, 2005 | 190 | 2005 |
| RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival N Shinomiya, CF Gao, Q Xie, M Gustafson, DJ Waters, YW Zhang, ... Cancer research 64 (21), 7962-7970, 2004 | 145 | 2004 |
| Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma Q Xie, R Bradley, L Kang, J Koeman, ML Ascierto, A Worschech, ... Proceedings of the National Academy of Sciences 109 (2), 570-575, 2012 | 143 | 2012 |
| Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles S Li, J Johnson, A Peck, Q Xie Journal of translational medicine 15 (1), 1-12, 2017 | 88 | 2017 |
| A highly invasive human glioblastoma pre-clinical model for testing therapeutics Q Xie, R Thompson, K Hardy, L DeCamp, B Berghuis, R Sigler, ... Journal of translational medicine 6 (1), 1-13, 2008 | 71 | 2008 |
| Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion Q Xie, CF Gao, N Shinomiya, E Sausville, R Hay, M Gustafson, Y Shen, ... Oncogene 24 (23), 3697-3707, 2005 | 65 | 2005 |
| SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma Q Xie, KD Liu, MY Hu, K Zhou World Journal of Gastroenterology 7 (6), 816, 2001 | 64 | 2001 |
| A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist WD Tolbert, J Daugherty, CF Gao, Q Xie, C Miranti, E Gherardi, ... Proceedings of the National Academy of Sciences 104 (37), 14592-14597, 2007 | 60 | 2007 |
| A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings BS Knudsen, P Zhao, J Resau, S Cottingham, E Gherardi, E Xu, ... Applied immunohistochemistry & molecular morphology: AIMM/official …, 2009 | 55 | 2009 |
| Insufficiency of DNA repair enzyme ATM promotes naive CD4 T-cell loss in chronic hepatitis C virus infection J Zhao, X Dang, P Zhang, LN Nguyen, D Cao, L Wang, X Wu, ... Cell Discovery 4 (1), 1-13, 2018 | 53 | 2018 |
| Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor … CF Gao, Q Xie, YW Zhang, Y Su, P Zhao, B Cao, K Furge, J Sun, K Rex, ... Molecular cancer therapeutics 8 (10), 2803-2810, 2009 | 44 | 2009 |
| Overexpression of HGF promotes HBV-induced hepatocellular carcinoma progression and is an effective indicator for Met-targeting therapy Q Xie, Y Su, K Dykema, J Johnson, J Koeman, V De Giorgi, A Huang, ... Genes & cancer 4 (7-8), 247-260, 2013 | 40 | 2013 |
| HCV-associated exosomes promote myeloid-derived suppressor cell expansion via inhibiting miR-124 to regulate T follicular cell differentiation and function L Wang, D Cao, L Wang, J Zhao, LN Nguyen, X Dang, Y Ji, XY Wu, ... Cell discovery 4 (1), 1-15, 2018 | 39 | 2018 |
| Phosphorothioate-modified AP613-1 specifically targets GPC3 when used for hepatocellular carcinoma cell imaging L Dong, H Zhou, M Zhao, X Gao, Y Liu, D Liu, W Guo, H Hu, Q Xie, J Fan, ... Molecular Therapy-Nucleic Acids 13, 376-386, 2018 | 35 | 2018 |
| Inhibition of TRF2 accelerates telomere attrition and DNA damage in naïve CD4 T cells during HCV infection LN Nguyen, J Zhao, D Cao, X Dang, L Wang, J Lian, Y Zhang, Z Jia, ... Cell death & disease 9 (9), 1-13, 2018 | 31 | 2018 |
| Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion Q Xie, R Wondergem, Y Shen, G Cavey, J Ke, R Thompson, R Bradley, ... Proceedings of the National Academy of Sciences 108 (10), 4105-4110, 2011 | 31 | 2011 |
| Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activation Y Shen, Q Xie, M Norberg, E Sausville, GV Woude, D Wenkert Bioorganic & medicinal chemistry 13 (16), 4960-4971, 2005 | 27 | 2005 |
| Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody J Kou, PR Musich, B Staal, L Kang, Y Qin, ZQ Yao, B Zhang, W Wu, A Tam, ... Journal of translational medicine 16 (1), 1-13, 2018 | 16 | 2018 |
| Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice Y Qin, A Musket, J Kou, J Preiszner, BR Tschida, A Qin, CA Land, B Staal, ... Neuro-oncology advances 2 (1), vdaa067, 2020 | 11 | 2020 |
